Xanthohumol is a hop-derived flavonoid that has been widely examined for its health-protecting and antitumorigenic properties, but not yet in a natural beer matrix. The aim of the study was to investigate the antitumorigenic potential of a xanthohumol-enriched beer in vivo. Four groups of 4 × 10 nude mice were formed. Following the injection of HeLa tumorigenic cell lines, the treatment groups were administered a xanthohumol supplementation for 100 days, either dissolved in beer or in an ethanolic solution with the same alcohol strength as beer. The control groups received un-supplemented material. The terminal tumor masses, liver weights, and plasma antioxidant capacities (FRAP and ABTS methods) were measured. For the statistical analysis, a two-way ANOVA test was performed (p < 0.05). There were no statistically significant differences in tumor size between the groups. Xanthohumol did not induce higher levels of plasma antioxidant capacity, neither in beer nor in the water-ethanol matrix. The terminal liver weights were significantly higher in the control group receiving the unsupplemented ethanol solution. Xanthohumol dissolved in beer or in the water-alcohol matrix did not have a protective effect on tumor growth, nor did it have a positive effect on plasma antioxidant capacity either. However, beer with added xanthohumol had a less harmful effect on the liver compared to the supplemented water-ethanol solution. Our results indicate the possible negative countereffect of ethanol; however, further investigations are needed.

Department of Biotechnology University of Chemistry and Technology Prague 166 28 Prague Czech Republic

Department of Dietetics and Nutritional Sciences Faculty of Health Sciences Semmelweis University 1088 Budapest Hungary

Doctoral School of Health Sciences Semmelweis University 1085 Budapest Hungary

NNK SSFO National Public Health Center 1097 Budapest Hungary

Research Institute of Brewing and Malting 120 00 Prague Czech Republic

Zobrazit více v PubMed

Vesaghhamedani S., Ebrahimzadeh F., Najafi E., Shabgah O.G., Askari E., Shabgah A.G., Mohammadi H., Jadidi-Niaragh F., Navashenaq J.G. Xanthohumol: An Underestimated, While Potent and Promising Chemotherapeutic Agent in Cancer Treatment. Prog. Biophys. Mol. Biol. 2022;172:3–14. doi: 10.1016/j.pbiomolbio.2022.04.002. PubMed DOI

Harish V., Haque E., Śmiech M., Taniguchi H., Jamieson S., Tewari D., Bishayee A. Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets. Int. J. Mol. Sci. 2021;22:4478. doi: 10.3390/ijms22094478. PubMed DOI PMC

Dokduang H., Yongvanit P., Namwat N. Xanthohumol Inhibits STAT3 Activation Pathway Leading to Growth Suppression and Apoptosis Induction in Human Cholangiocarcinoma Cells. Oncol. Rep. 2016;35:2065–2072. doi: 10.3892/or.2016.4584. PubMed DOI

Saito K., Matsuo Y., Imafuji H., Okubo T., Maeda Y., Sato T., Shamoto T., Tsuboi K., Morimoto M., Takahashi H., et al. Xanthohumol Inhibits Angiogenesis by Suppressing Nuclear Factor-ΚB Activation in Pancreatic Cancer. Cancer Sci. 2018;109:132–140. doi: 10.1111/cas.13441. PubMed DOI PMC

Shikata Y., Yoshimaru T., Komatsu M., Katoh H., Sato R., Kanagaki S., Okazaki Y., Toyokuni S., Tashiro E., Ishikawa S., et al. Protein Kinase A Inhibition Facilitates the Antitumor Activity of Xanthohumol, a Valosin-Containing Protein Inhibitor. Cancer Sci. 2017;108:785–794. doi: 10.1111/cas.13175. PubMed DOI PMC

Sun Z., Zhou C., Liu F., Zhang W., Chen J., Pan Y., Ma L., Liu Q., Du Y., Yang J., et al. Inhibition of Breast Cancer Cell Survival by Xanthohumol via Modulation of the Notch Signaling Pathway in Vivo and in Vitro. Oncol. Lett. 2018;15:908–916. doi: 10.3892/ol.2017.7434. PubMed DOI PMC

Venè R., Benelli R., Minghelli S., Astigiano S., Tosetti F. Xanthohumol Impairs Human Prostate Cancer Cell Growth and Invasion and Diminishes the Incidence and Progression of Advanced Tumors in TRAMP Mice. Mol. Med. 2012;18:1292–1302. doi: 10.2119/molmed.2012.00174. PubMed DOI PMC

Walden D., Kunnimalaiyaan S., Sokolowski K., Gamblin T.C., Kunnimalaiyaan M. Antiproliferative and Apoptotic Effects of Xanthohumol in Cholangiocarcinoma. Oncotarget. 2017;8:88069–88078. doi: 10.18632/oncotarget.21422. PubMed DOI PMC

Venturelli S., Burkard M., Biendl M., Lauer U.M., Frank J., Busch C. Prenylated Chalcones and Flavonoids for the Prevention and Treatment of Cancer. Nutrition. 2016;32:1171–1178. doi: 10.1016/j.nut.2016.03.020. PubMed DOI

Éliás A.J., Bodor Z., Benedek C. Xanthohumol from Hop (Humulus lupulus L.) In: Goyal M.R., Nath A., Kovács Z., editors. Sustainable and Functional Foods from Plants. Apple Academic Press; Palm Bay, FL, USA: 2022.

Zugravu C.A., Bohiltea R.E., Salmen T., Pogurschi E., Otelea M.R. Antioxidants in Hops: Bioavailability, Health Effects and Perspectives for New Products. Antioxidants. 2022;11:241. doi: 10.3390/antiox11020241. PubMed DOI PMC

Ciriminna R., Albanese L., Di Stefano V., Delisi R., Avellone G., Meneguzzo F., Pagliaro M. Beer Produced via Hydrodynamic Cavitation Retains Higher Amounts of Xanthohumol and Other Hops Prenylflavonoids. Lwt. 2018;91:160–167. doi: 10.1016/j.lwt.2018.01.037. DOI

Karabín M., Jelínek L., Hudcová T., Kotlíková B., Dostálek P. New Approach to the Production of Xanthohumol-Enriched Beers. J. Inst. Brew. 2013;119:98–102. doi: 10.1002/jib.71. DOI

Protsenko L., Rudyk R., Hryniuk T., Vlasenko A., Protsenko A., Litvynchuk S., Ovadenko O. Beer Enrichment with Biologically Active Hop Compounds. Ukr. Food J. 2018;7:65–78. doi: 10.24263/2304-974X-2018-7-1-7. DOI

Wunderlich S., Zürcher A., Back W. Enrichment of Xanthohumol in the Brewing Process. Mol. Nutr. Food Res. 2005;49:874–881. doi: 10.1002/mnfr.200500051. PubMed DOI

Lugasi A. Polyphenol Content and Antioxidant Properties of Beer. Acta Aliment. 2003;32:181–192. doi: 10.1556/AAlim.32.2003.2.7. DOI

Koren D., Kun S., Hegyesné Vecseri B., Kun-Farkas G. Study of Antioxidant Activity during the Malting and Brewing Process. J. Food Sci. Technol. 2019;56:3801–3809. doi: 10.1007/s13197-019-03851-1. PubMed DOI PMC

Shishehbor F., Shahi M.M., Zarei M., Saki A., Shirani F., Zare M. Effects of Concentrated Pomegranate Juice on Subclinical Inflammation and Cardiometabolic Risk Factors for Type 2 Diabetes : A Quasi- Experimental Study. Int. J. Endocrinol. Metab. 2016;14:e338835. doi: 10.5812/ijem.33835. PubMed DOI PMC

Gasowski B., Leontowicz M., Leontowicz H., Katrich E., Lojek A., Číž M., Trakhtenberg S., Gorinstein S. The Influence of Beer with Different Antioxidant Potential on Plasma Lipids, Plasma Antioxidant Capacity, and Bile Excretion of Rats Fed Cholesterol-Containing and Cholesterol-Free Diets. J. Nutr. Biochem. 2004;15:527–533. doi: 10.1016/j.jnutbio.2004.03.004. PubMed DOI

Secretan B., Straif K., Baan R., Grosse Y., El Ghissassi F., Bouvard V., Benbrahim-Tallaa L., Guha N., Freeman C., Galichet L., et al. A Review of Human Carcinogens—Part E: Tobacco, Areca Nut, Alcohol, Coal Smoke, and Salted Fish. Lancet Oncol. 2009;10:1033–1034. doi: 10.1016/S1470-2045(09)70326-2. PubMed DOI

Dorn C., Kraus B., Motyl M., Weiss T.S., Gehrig M. Xanthohumol, a Chalcon Derived from Hops, Inhibits Hepatic Inflammation and Fibrosis. Mol. Nutr. Food Res. 2010;54:205–213. doi: 10.1002/mnfr.200900314. PubMed DOI

Kanuri G., Wagnerberger S., Landmann M., Prigl E., Hellerbrand C., Bischoff S.C., Bergheim I. Effect of Acute Beer Ingestion on the Liver : Studies in Female Mice. Eur. J. Nutr. 2015;54:465–474. doi: 10.1007/s00394-014-0730-z. PubMed DOI

Landmann M., Wagnerberger S., Kanuri G., Ziegenhardt D., Bergheim I. Beer Is Less Harmful for the Liver than Plain Ethanol : Studies in Male Mice Using a Binge-Drinking Model. Alcohol Alcohol. 2015;50:493–500. doi: 10.1093/alcalc/agv048. PubMed DOI

Landmann M., Sellmann C., Engstler A.J., Ziegenhardt D., Jung F., Brombach C., Bergheim I. Hops (Humulus lupulus) Content in Beer Modulates Effects of Beer on the Liver after Acute Ingestion in Female Mice. Alcohol Alcohol. 2017;52:48–55. doi: 10.1093/alcalc/agw060. PubMed DOI

Osorio-Paz I., Brunauer R., Alavez S. Beer and Its Non-Alcoholic Compounds in Health and Disease. Crit. Rev. Food Sci. Nutr. 2020;60:3492–3505. doi: 10.1080/10408398.2019.1696278. PubMed DOI

Griswold M.G., Fullman N., Hawley C., Arian N., Zimsen S.R.M., Tymeson H.D., Venkateswaran V., Tapp A.D., Forouzanfar M.H., Salama J.S., et al. Alcohol Use and Burden for 195 Countries and Territories, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392:1015–1035. doi: 10.1016/S0140-6736(18)31310-2. PubMed DOI PMC

Ferk F., Huber W.W., Filipič M., Bichler J., Haslinger E., Mišík M., Nersesyan A., Grasl-Kraupp B., Žegura B., Knasmüller S. Xanthohumol, a Prenylated Flavonoid Contained in Beer, Prevents the Induction of Preneoplastic Lesions and DNA Damage in Liver and Colon Induced by the Heterocyclic Aromatic Amine Amino-3-Methyl-Imidazo [4, 5-f ] Quinoline (IQ) Mutat. Res. / Fundam. Mol. Mech. Mutagen. 2010;691:17–22. doi: 10.1016/j.mrfmmm.2010.06.006. PubMed DOI

Arjomandnejad M., Muhammadnejad A., Haddadi M., Sherkat-Khameneh N., Rismanchi S., Amanpour S., Muhammadnejad S. Hela Cell Line Xenograft Tumor as a Suitable Cervical Cancer Model: Growth Kinetic Characterization and Immunohistochemis-Try Array. Arch. Iran. Med. 2014;17:273–277. PubMed

Rocha-Guzmán N.E., Gallegos-Infante J.A., González-Laredo R.F., Reynoso-Camacho R., Ramos-Gómez M., Garcia-Gasca T., Rodríguez-Muñoz M.E., Guzmán-Maldonado S.H., Medina-Torres L., Lujan-García B.A. Antioxidant Activity and Genotoxic Effect on HeLa Cells of Phenolic Compounds from Infusions of Quercus Resinosa Leaves. Food Chem. 2009;115:1320–1325. doi: 10.1016/j.foodchem.2009.01.050. DOI

Ruginǎ D., Sconţa Z., Leopold L., Pintea A., Bunea A., Socaciu C. Antioxidant Activities of Chokeberry Extracts and the Cytotoxic Action of Their Anthocyanin Fraction on Hela Human Cervical Tumor Cells. J. Med. Food. 2012;15:700–706. doi: 10.1089/jmf.2011.0246. PubMed DOI PMC

Ferk F., Mišík M., Nersesyan A., Pichler C., Jäger W., Szekeres T., Marculescu R., Poulsen H.E., Henriksen T., Bono R., et al. Impact of Xanthohumol (a Prenylated Flavonoid from Hops) on DNA Stability and Other Health-Related Biochemical Parameters: Results of Human Intervention Trials. Mol. Nutr. Food Res. 2016;60:773–786. doi: 10.1002/mnfr.201500355. PubMed DOI

Varela-Rey M., Woodhoo A., Maria-Luz M.-C., Mato J., Lu S. Alcohol, {DNA} Methylation, and Cancer. Alcohol Res. 2013;35:25–35. doi: 10.4067/S0370-41062008000700008. PubMed DOI PMC

Ratna A., Mandrekar P. Alcohol and Cancer : Mechanisms and Therapies. Biomolecules. 2017;7:61. doi: 10.3390/biom7030061. PubMed DOI PMC

Theodoratou E., Timofeeva M., Li X., Meng X., Ioannidis J.P.A. Nature, Nurture and Cancer Risks : Genetic and Nutritional Contributions to Cancer. Annu. Rev. Nutr. 2017;37:293–320. doi: 10.1146/annurev-nutr-071715-051004. PubMed DOI PMC

Caulfeild J., Hong S., Teufel K., Trevithick J.R., Vinson J.A., Derksen T., Bocksch L., Trevithick C.C., Rahman F., Hirst M., et al. Is Ethanol an Important Antioxidant in Alcoholic Beverages Associated with Risk Reduction of Cataract and Atherosclerosis? Redox Rep. 2004;4:89–93. doi: 10.1179/135100099101534765. PubMed DOI

Arts M.J.T.J., Haenen G.R.M.M., Voss H., Bast A. Masking of Antioxidant Capacity by the Interaction of Flavonoids with Protein. Food Chem. Toxicol. 2001;39:787–791. doi: 10.1016/S0278-6915(01)00020-5. PubMed DOI

Belščak A., Komes D., Horžić D., Ganić K.K., Karlović D. Comparative Study of Commercially Available Cocoa Products in Terms of Their Bioactive Composition. Food Res. Int. 2009;42:707–716. doi: 10.1016/j.foodres.2009.02.018. DOI

Ozdal T., Capanoglu E., Altay F. A Review on Protein-Phenolic Interactions and Associated Changes. Food Res. Int. 2013;51:954–970. doi: 10.1016/j.foodres.2013.02.009. DOI

du Sert N.P., Ahluwalia A., Alam S., Avey M.T., Baker M., Browne W.J., Clark A., Cuthill I.C., Dirnagl U., Emerson M., et al. Reporting Animal Research: Explanation and Elaboration for the Arrive Guidelines 2.0. PLoS Biol. 2020;18:1–65. doi: 10.1371/journal.pbio.3000411. PubMed DOI PMC

World Health Organization WHO Expert Committee on Biological Standardization, Annex 3: Reccomendations for the Evaluation of Animal Cell Cultures as Substrates for the Manufacture of Biological Medicinal Products and for the Characterization of Cell Banks. World Health Organ. Tech. Rep. Ser. 2013:79–187.

Krofta K. The Content of Hop Prenylflavonoids in Czech and Foreign Beers. Kvas. Prum. 2010;56:2–9. doi: 10.18832/kp2010001. DOI

Cayman Chemical Company Product Information Xanthohumol. [(accessed on 7 April 2021)]. Available online: https://cdn.caymanchem.com/cdn/insert/15399.pdf.

Enzo Life Sciences Xanthohumol. [(accessed on 12 August 2020.)]. Available online: https://www.enzolifesciences.com/alx-350-280/xanthohumol/

Benzie I.F.F., Strain J.J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of ‘“Antioxidant Power”’. The FRAP Assay. 1996;239:70–76. doi: 10.1006/abio.1996.0292. PubMed DOI

Re R., Pellegrini N., Proteggenete A., Pannala A., Yang M., Rice-Evans C. Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay. Free Radic. Biol. Med. 1999;26:1231–1237. doi: 10.1016/S0891-5849(98)00315-3. PubMed DOI

Effect Size—A Quick Guide. [(accessed on 3 January 2023)]. Available online: https://www.spss-tutorials.com/effect-size/

Vanhoecke B.W., Delporte F., Braeckel E.V.A.V.A.N., Heyerick A., Depypere H.T., Nuytinck M., Keukeleire D.D.E., Bracke M.E. A Safety Study of Oral Tangeretin and Xanthohumol Administration to Laboratory Mice. In Vivo. 2005;19:103–107. PubMed

Dorn C., Bataille F., Gaebele E., Heilmann J., Hellerbrand C. Xanthohumol Feeding Does Not Impair Organ Function and Homoeostasis in Mice. Food Chem. Toxicol. 2010;48:1890–1897. doi: 10.1016/j.fct.2010.04.030. PubMed DOI